CommunicationNCT04806984
Improving Gap Closure Rates Using a Predictive Model
An observational study of Communication and Appointments and Schedules, run by NYU Langone Health at 1 site in United States.
Trial summary
NYU Langone Health outreaches to patients to remind them to schedule their appointments by phone or MyChart message.The proposed study will test different outreach methods using a predictive risk model. The goal is to increase gap closure rate by the end of the year. Read more about this study
- Who is it for?
- Ages 3 years and older
- Conditions the study is for
- Communication, Appointments and Schedules
- What is being tested?
- Participant outreach
- How many people
- 34,896 participants
- Where
- 1 siteUnited States
- Study dates
- 9 Feb 2021to 27 Feb 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patients in the NYU Langone network
Who may be able to join
- Patients in the NYU Langone network who are due for gaps in care.
Who cannot join
- Patients in the NYU Langone network are not due for gaps in care.
Trial locations and contacts
1 site in 1 country.
About this study
NYU Langone Health outreaches to patients to remind them to schedule their appointments by phone or MyChart message.The proposed study will test different outreach methods using a predictive risk model. The goal is to increase gap closure rate by the end of the year.
- Conditions
- Communication, Appointments and Schedules
- Being tested
- Participant outreach
- Medical subject headings
- Communication
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Participant outreachOther
Participants in the experimental arms will receive a call center phone call or MyChart message to remind them to schedule their appointments.
| Study group | Role | What they receive |
|---|---|---|
| Call center phone call | Participants randomized to this arm will receive a phone call from the call center reminding them to schedule their appointments. Receives: Other: Participant outreach | |
| No call center phone call | Participants randomized to this arm will not receive a phone call from the call center reminding them to schedule their appointments. | |
| MyChart message | Participants randomized to this arm will receive an automated MyChart message reminding them to schedule their appointments. Receives: Other: Participant outreach | |
| No MyChart message | Participants randomized to this arm will not receive an automated MyChart message reminding them to schedule their appointments. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Gap closure rate
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Mar 2021
- Study start9 Feb 2021
- Primary completion27 Feb 2022
- Study completion27 Feb 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CommunicationStudies of the same condition, open and under way.
- More trials run by NYU Langone HealthThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 34,896 participants (actual)
Sponsor and investigators
- Lead sponsor
- NYU Langone Health
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Leora Horwitz, MD, Principal investigator, NYU Langone Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04806984
- Sponsor's protocol ID
- QI-CIN Gaps Predictive Model
- Status last verified
- Mar 2023
- First submitted
- 5 Mar 2021
- Last updated
- 28 Mar 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Mar 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Improving Gap Closure Rates Using a Predictive Model
- ClinicalTrials.gov ID
- NCT04806984
- Acronym / sponsor ID
- QI-CIN Gaps Predictive Model
- Conditions
- Communication, Appointments and Schedules
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 34,896 participants (actual)
- Lead sponsor
- NYU Langone HealthUniversity, hospital or other
- Study start
- 9 Feb 2021 (actual)
- Primary completion
- 27 Feb 2022 (actual)
- Study completion
- 27 Feb 2022 (actual)
- First posted
- 19 Mar 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
NYU Langone Health outreaches to patients to remind them to schedule their appointments by phone or MyChart message.The proposed study will test different outreach methods using a predictive risk model. The goal is to increase gap closure rate by the end of the year.
Study design
- Observational model
- Other
- Time perspective
- Other
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Call center phone call | – | Other: Participant outreachParticipants randomized to this arm will receive a phone call from the call center reminding them to schedule their appointments. |
| No call center phone call | – | –Participants randomized to this arm will not receive a phone call from the call center reminding them to schedule their appointments. |
| MyChart message | – | Other: Participant outreachParticipants randomized to this arm will receive an automated MyChart message reminding them to schedule their appointments. |
| No MyChart message | – | –Participants randomized to this arm will not receive an automated MyChart message reminding them to schedule their appointments. |
Who may qualify
- Ages
- 3 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patients in the NYU Langone network
Key inclusion criteria (1 listed)
- Patients in the NYU Langone network who are due for gaps in care.
Key exclusion criteria (1 listed)
- Patients in the NYU Langone network are not due for gaps in care.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Participant outreachParticipants in the experimental arms will receive a call center phone call or MyChart message to remind them to schedule their appointments. | Other | Call center phone call, MyChart message |
Primary outcome
Gap closure rate
Time frame: 1 year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Mar 2023.
- Individual participant dataSharing planned: No
Related trials for Communication
Recruiting
Using Non-invasive Brain Stimulation to Explore Potential Treatments to Reduce Speech Errors in Adults Who Stutter
Stuttering, Fluency Disorder
Recruiting
Vowel Space Expansion Sensorimotor Adaptation
Speech
RecruitingObservational study
Implementing Transcranial Direct Current Stimulation in a Rehabilitation Setting
Aphasia, Stroke
RecruitingObservational study
Speech and Language Interventions for Italian People With PPA
Primary Progressive Aphasia(PPA)
Recruiting
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)
Brainstem Stroke, ALS
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Leora Horwitz, MD principal investigator
NYU Langone Health
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Communication and Appointments and Schedules, run by NYU Langone Health at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Gap closure rate (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Mar 2023.